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Background
ANA is an important diagnostic tool in PAID. The type
of staining patterns by IFF technique and the final titer
varies according of the type of PAID.
Aim
To evaluate the ANA type of patterns and titer on a
cohort of PAID patients in a referral pediatric rheuma-
tology center in Bogotá.
Methods
Retrospective descriptive study of a PAID cohort.
Results
363 patients were included. 66% had JIA, 11% JSLE, 7%
juvenile undifferentiated autoimmune disease(JUAD), 4%
Scleroderma, 4% JDM, 1% uveitis ANA + and a group
of other PAID 11%. ANA positivity varies according to
the subtype of JIA from 0-68%. Positive AAN: JSLE
93%, scleroderma 85%, JDM 63%. Most JUAD had ANA
+ at low titers. A heterogeneous group of other PAID
showed a variable titers and patterns of ANA .The most
prevalent type of pattern was speckled, followed by
homogenous and other pattern were uncommon. On
JSLE, the prevalence and titers were higher and multiple
auto antibodies were detected at the time of diagnosis.
(Table 1).
Conclusion
ANA positivity is not specific for PAID. Its interpreta-
tion should be based on a good clinical correlation and
additional work up in order to classified and confirm
PAID.
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Table 1
Disease N ANA
+
Speckled Homogeneous ≤1:320 >1:320
JIA 98/
240
41% 96% 4% 91% 9%
JSLE 37/40 93% 70% 24% 35% 65%
JUAD 24/24 100% 83% 13% 63% 37%
JDM 8/13 62% 62% 38% 88% 12%
Scleroderma 11/13 85% 82% 18% 55% 45%
Other PAID 24/31 71% 71% 21% 67% 33%
Uveitis ANA
+
3/3 100% 100% 0% 100% 0%
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